B
Abbott Laboratories ABT
$132.81 $0.8050.61% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 1.78B 1.33B 9.23B 1.65B 1.30B
Total Depreciation and Amortization 777.00M 756.00M 807.00M 801.00M 805.00M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 142.00M 289.00M 593.00M 117.00M 141.00M
Change in Net Operating Assets -651.00M -953.00M -7.76B 141.00M -288.00M
Cash from Operations 2.05B 1.42B 2.87B 2.71B 1.96B
Capital Expenditure -502.00M -484.00M -720.00M -556.00M -533.00M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -30.00M -- -- -- --
Divestitures -- -- 0.00 0.00 1.00M
Other Investing Activities -50.00M 14.00M -146.00M -38.00M 79.00M
Cash from Investing -582.00M -470.00M -866.00M -594.00M -453.00M
Total Debt Issued 2.00M 1.00M 1.00M 1.00M 221.00M
Total Debt Repaid -17.00M -1.04B -614.00M 42.00M -61.00M
Issuance of Common Stock 35.00M 287.00M 25.00M 92.00M 13.00M
Repurchase of Common Stock -6.00M -280.00M -315.00M -751.00M -3.00M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -1.03B -1.03B -958.00M -960.00M -961.00M
Other Financing Activities -82.00M -- -- -- --
Cash from Financing -1.10B -2.06B -1.86B -1.58B -791.00M
Foreign Exchange rate Adjustments 51.00M 24.00M -83.00M 36.00M -13.00M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 419.00M -1.08B 58.00M 571.00M 703.00M